Why Clorox (CLX) Could Beat Earnings Estimates Again

20.01.25 18:10 Uhr

Werte in diesem Artikel
Aktien

155,40 EUR -0,60 EUR -0,38%

Indizes

5.996,7 PKT 59,3 PKT 1,00%

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Clorox (CLX), which belongs to the Zacks Consumer Products - Staples industry.This consumer products maker has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 27.47%.For the last reported quarter, Clorox came out with earnings of $1.86 per share versus the Zacks Consensus Estimate of $1.36 per share, representing a surprise of 36.76%. For the previous quarter, the company was expected to post earnings of $1.54 per share and it actually produced earnings of $1.82 per share, delivering a surprise of 18.18%.Thanks in part to this history, there has been a favorable change in earnings estimates for Clorox lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.Clorox has an Earnings ESP of +1.89% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #2 (Buy), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on February 3, 2025.Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Clorox Company (CLX): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Clorox

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Clorox

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Clorox Co., The

Wer­bung

Analysen zu Clorox Co., The

DatumRatingAnalyst
02.05.2019Clorox HoldDeutsche Bank AG
14.12.2017Clorox HoldDeutsche Bank AG
09.01.2017Clorox Equal WeightBarclays Capital
16.12.2016Clorox OutperformBMO Capital Markets
03.11.2016Clorox Sector PerformRBC Capital Markets
DatumRatingAnalyst
16.12.2016Clorox OutperformBMO Capital Markets
06.02.2015Clorox BuyArgus Research Company
05.12.2014Clorox BuyArgus Research Company
09.07.2012Clorox kaufenEuro am Sonntag
16.02.2011Clorox outperformRBC Capital Markets
DatumRatingAnalyst
02.05.2019Clorox HoldDeutsche Bank AG
14.12.2017Clorox HoldDeutsche Bank AG
09.01.2017Clorox Equal WeightBarclays Capital
03.11.2016Clorox Sector PerformRBC Capital Markets
05.05.2016Clorox NeutralB. Riley & Co., LLC
DatumRatingAnalyst
04.05.2016Clorox SellUBS AG
03.11.2015Clorox SellUBS AG
07.10.2015Clorox UnderweightBarclays Capital
23.09.2014Clorox SellB. Riley & Co., LLC
03.02.2006Update Clorox Co., The: SellOppenheimer

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Clorox Co., The nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"